JP2024501872A5 - - Google Patents
Info
- Publication number
- JP2024501872A5 JP2024501872A5 JP2023540488A JP2023540488A JP2024501872A5 JP 2024501872 A5 JP2024501872 A5 JP 2024501872A5 JP 2023540488 A JP2023540488 A JP 2023540488A JP 2023540488 A JP2023540488 A JP 2023540488A JP 2024501872 A5 JP2024501872 A5 JP 2024501872A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063133156P | 2020-12-31 | 2020-12-31 | |
| US63/133,156 | 2020-12-31 | ||
| US202163181439P | 2021-04-29 | 2021-04-29 | |
| US63/181,439 | 2021-04-29 | ||
| PCT/US2021/065624 WO2022147207A1 (en) | 2020-12-31 | 2021-12-30 | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024501872A JP2024501872A (ja) | 2024-01-16 |
| JPWO2022147207A5 JPWO2022147207A5 (https=) | 2025-01-14 |
| JP2024501872A5 true JP2024501872A5 (https=) | 2025-01-14 |
Family
ID=82261078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023540488A Pending JP2024501872A (ja) | 2020-12-31 | 2021-12-30 | 顔面肩甲上腕筋ジストロフィーを処置するための筋標的化複合体およびそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240110184A1 (https=) |
| EP (1) | EP4271478A4 (https=) |
| JP (1) | JP2024501872A (https=) |
| KR (1) | KR20230128314A (https=) |
| CA (1) | CA3202826A1 (https=) |
| IL (1) | IL304049A (https=) |
| WO (1) | WO2022147207A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| EP3829595A4 (en) | 2018-08-02 | 2022-08-24 | Dyne Therapeutics, Inc. | MUSCLE-DIRECTED COMPLEXES AND USES THEREOF IN THE TREATMENT OF DYSTROPHINOPATHIES |
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US20220193250A1 (en) | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US11672872B2 (en) | 2021-07-09 | 2023-06-13 | Dyne Therapeutics, Inc. | Anti-transferrin receptor antibody and uses thereof |
| IL309936A (en) | 2021-07-09 | 2024-03-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of dystrophinopathy |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
| US11633498B2 (en) | 2021-07-09 | 2023-04-25 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US20250339553A1 (en) | 2022-04-15 | 2025-11-06 | Dyne Therapeutics, Inc. | Muscle targeting complexes and formulations for treating myotonic dystrophy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109310765A (zh) * | 2016-06-20 | 2019-02-05 | 领先基因生物技术股份有限公司 | 抗体-药物偶联物 |
| AU2018345772B2 (en) * | 2017-10-02 | 2025-04-17 | Research Institute At Nationwide Children's Hospital | MiRNA detargeting system for tissue specific interference |
| US20220193250A1 (en) * | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| CN119874910A (zh) * | 2019-06-07 | 2025-04-25 | 达因疗法公司 | 制备蛋白质-寡核苷酸复合物的方法 |
-
2021
- 2021-12-30 JP JP2023540488A patent/JP2024501872A/ja active Pending
- 2021-12-30 EP EP21916465.4A patent/EP4271478A4/en active Pending
- 2021-12-30 KR KR1020237025561A patent/KR20230128314A/ko active Pending
- 2021-12-30 WO PCT/US2021/065624 patent/WO2022147207A1/en not_active Ceased
- 2021-12-30 CA CA3202826A patent/CA3202826A1/en active Pending
- 2021-12-30 IL IL304049A patent/IL304049A/en unknown
- 2021-12-30 US US18/270,284 patent/US20240110184A1/en active Pending